Reclinica Corp

Website
600 W Santa Ana Blvd Ste 1100
Santa Ana, CA 92701
https://www.reclinica.com

Reclinica Corp, located in Santa Ana, CA, provides a range of services designed to facilitate engagement with sponsors and volunteers while maintaining a strong commitment to privacy and data security. The company is dedicated to collecting, processing, and utilizing personal information in a transparent manner, ensuring that users are informed of their rights and the extent of data usage.

Through its various platforms, Reclinica collects personal information voluntarily shared by users, as well as data obtained from automated processes and third-party sources, to enhance user experience and deliver relevant marketing offers. By prioritizing user consent and compliance with legal obligations, Reclinica aims to foster a trustworthy environment for all stakeholders in its community.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Xostem Inc

Independent Testing Labs
Business services, nec, nec, Product testing laboratories

Independent Testing Labs

3
"The Go-TO Test lab here in Socal. They are flexible and knowledegable about the test specs and have all the gear you need to test your electronic gear. Always nerve-wrackaing to put our gear..."
photo of Greg B.

Seq Biomarque LLC

Seq Biomarque LLC, based in Anaheim, CA, is a leading research company focused on developing molecular blood-based biomarker tests for Alzheimer's Disease (AD). With guidance from global leaders in AD clinical research, their scientific team is working on a non-invasive, highly sensitive, and cost-effective diagnostic test that evaluates biomarkers throughout the three phases of the disease. Seq Biomarque is particularly interested in novel biomarkers associated with early detection and the preclinical stages of AD, as well as mid- to late-stage biomarkers for monitoring therapeutic efficacy. As part of their research, Seq Biomarque is developing biomarker tests for traditional markers of AD pathology, such as Tau and Beta-Amyloid, while also focusing on novel blood-based biomarkers directly relevant to the diagnostic AD continuum. Their goal is to create a multifactor AD biomarker panel that complements existing clinical assessments and neuro-imaging tests, providing additional information for optimal therapeutic AD patient care. With an expandable test platform, Seq Biomarque aims to include new biomarkers and conduct high-throughput simultaneous testing of multiple independent specimens.Generated from the website
United States›California›Santa Ana›Reclinica Corp

Partial Data by Infogroup (c) 2025. All rights reserved.